Skip to main content
Back

Immune Response Diseases and Preventable Diseases: Hypersensitivities, Autoimmunity, and Vaccination

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Immune Response Diseases

Hypersensitivities

Hypersensitivities are inappropriate or exaggerated immune responses that result in host tissue damage. They are classified into four main types based on their immune mechanisms and clinical manifestations.

  • Type I (Immediate) Hypersensitivity: Mediated by IgE antibodies, this type is commonly associated with allergies and occurs within minutes of exposure to an allergen. Symptoms can range from mild (hay fever) to severe (anaphylactic shock).

  • Type II (Cytotoxic) Hypersensitivity: Involves IgG or IgM antibodies directed against antigens on host cell surfaces, leading to cell destruction via complement activation or antibody-dependent cellular cytotoxicity.

  • Type III (Immune Complex-Mediated) Hypersensitivity: Characterized by the formation of antigen-antibody complexes that deposit in tissues, triggering inflammation and tissue injury.

  • Type IV (Delayed-Type) Hypersensitivity: A cell-mediated response involving T cells, with maximal reaction occurring 24–48 hours after antigen exposure. Common examples include contact dermatitis and the tuberculin skin test.

Superantigens are pathogen-derived proteins that cause excessive activation of T cells, resulting in massive cytokine release and systemic inflammation, which can be damaging to the host.

Type I Hypersensitivity: Mechanism and Examples

Type I hypersensitivity involves a two-step process:

  • Primary response: Allergen exposure stimulates TH2 cells to secrete cytokines, causing B cells to produce IgE antibodies. These IgE antibodies bind to mast cell receptors.

  • Secondary response: Upon re-exposure, the allergen cross-links IgE on mast cells, triggering degranulation and release of mediators such as histamine, leading to allergic symptoms.

  • Examples: Hay fever, asthma, reactions to bee stings, animal dander, and latex.

  • Treatment: Removal of allergen, antihistamines, steroids, adrenalin, and desensitization therapy.

Mechanism of Type I Hypersensitivity (Allergy)

Type IV Hypersensitivity (Delayed-Type)

Type IV hypersensitivity is mediated by T cells and does not involve antibodies. The response peaks 24–48 hours after antigen exposure. Typical antigens include microbial proteins (e.g., Mycobacterium tuberculosis), self-antigens (as in autoimmune diseases), and chemicals that bind to skin proteins (e.g., poison ivy).

  • Mechanism: Antigen-presenting cells present antigen to TH1 cells, which release cytokines, activating macrophages and causing inflammation.

  • Examples: Tuberculin skin test, contact dermatitis.

Type IV Hypersensitivity: T cell and macrophage interaction Tuberculin skin test (Type IV hypersensitivity)

Autoimmune Diseases

Mechanisms and Examples

Autoimmune diseases occur when the immune system mounts a response against self-antigens, leading to tissue damage. These diseases may be mediated by antibodies (Type II and III hypersensitivities) or T cells (Type IV hypersensitivity).

  • Type II: Antibodies bind to self-antigens on host cells, leading to cell destruction (e.g., Goodpasture’s syndrome, Myasthenia gravis).

  • Type III: Immune complexes deposit in tissues, causing inflammation (e.g., systemic lupus erythematosus, rheumatoid arthritis).

  • Type IV: T cell-mediated destruction of self-tissues (e.g., multiple sclerosis, Type 1 diabetes).

Disease

Target

Mechanism

Type 1 diabetes

Pancreatic beta cells

Cell-mediated and autoantibody (Type II & IV)

Myasthenia gravis

Skeletal muscle

Autoantibodies to acetylcholine receptor (Type II)

Goodpasture’s syndrome

Kidney

Autoantibodies to basement membrane (Type II)

Rheumatoid arthritis

Joints

Immune complexes (Type III)

Systemic lupus erythematosus

Multiple tissues

Immune complexes (Type III)

Multiple sclerosis

Central nervous system

Cell-mediated and autoantibody (Type II & IV)

Superantigens

Mechanism and Clinical Impact

Superantigens are microbial proteins that bind outside the conventional antigen-binding site of the T cell receptor and MHC class II molecule, causing non-specific activation of a large number of T cells. This leads to excessive cytokine production and systemic inflammatory responses, such as toxic shock syndrome and certain types of food poisoning.

Superantigen mechanism: bridging TCR and MHC II

Summary of Hypersensitivity Types

Type

Description

Immune Mechanism

Latency

Examples

I

Immediate

IgE sensitization of mast cells

Minutes

Bee sting, hay fever

II

Cytotoxic

IgG interaction with cell surface antigen

Hours

Drug reactions (penicillin)

III

Immune complex

IgG interaction with soluble antigen

Hours

Systemic lupus erythematosus

IV

Delayed type

TH1 cell activation of macrophages

Days (24–48 h)

Poison ivy, tuberculin test

Immunity: Natural vs. Artificial, Passive vs. Active

Definitions and Mechanisms

  • Active Immunity: The host produces its own immune response after exposure to antigen. Can be natural (infection) or artificial (vaccination).

  • Passive Immunity: The host receives antibodies or immune cells from another source. Can be natural (maternal antibodies) or artificial (antiserum, antitoxin).

Natural immunity: active and passive Artificial immunity: active and passive

Neutralization of Exotoxins by Antitoxins

Antitoxins are antibodies that bind to and neutralize exotoxins, preventing them from damaging host cells. This is a form of passive immunity, often used in cases of toxin-mediated diseases.

Neutralization of exotoxin by antitoxin antibody

Comparison of Active and Passive Immunity

Active Immunity

Passive Immunity

Exposure to antigen; immune response generated by host

No exposure to antigen; antibodies or cells provided by donor

Memory cells produced; long-lasting

No memory; short-lived

Develops over weeks

Immediate protection

Vaccination and Herd Immunity

History and Importance

Vaccination is the process of inducing active immunity by exposing individuals to antigens in a controlled manner. The concept of herd immunity refers to the resistance of a population to infection when a high proportion of individuals are immune, thereby protecting susceptible individuals.

Herd immunity: disease transmission blocked

Immunization Recommendations

Routine immunization schedules are established to protect infants and children from common infectious diseases. These schedules are often mandated by law for school entry.

Infant immunization: recommended vaccines Louisiana immunization law

Measles, Mumps, and Rubella (MMR) Vaccine

Diseases and Vaccine Impact

  • Measles: Caused by a paramyxovirus; symptoms include fever, rash, and complications such as pneumonia and encephalitis. The rash is likely due to a Type IV hypersensitivity response.

  • Mumps: Caused by a paramyxovirus; characterized by swollen salivary glands.

  • Rubella: Caused by a togavirus; can cause congenital defects if contracted during pregnancy.

  • MMR Vaccine: Contains attenuated viruses for all three diseases and has dramatically reduced their incidence.

MMR vaccine impact on disease incidence Measles virus electron micrograph Measles rash, mumps swollen glands, rubella cataract MMR vaccine saves lives: disease incidence graphs

Vaccine Safety: Thiomersal (Thimerosal)

Thiomersal is a mercury-containing compound previously used as a preservative in some vaccines. Extensive studies have shown no link between thiomersal and autism.

Thiomersal chemical structure

Types of Vaccines

Classifications and Examples

  • Toxoid: Chemically inactivated toxins that retain antigenicity (e.g., tetanus, diphtheria).

  • Surface protein: Purified or inactivated proteins from pathogens (e.g., pertussis).

  • Killed cells/inactivated virus: Pathogens killed by heat or chemicals (e.g., typhoid, influenza).

  • Live attenuated: Weakened strains that induce strong immunity (e.g., MMR, BCG).

  • Conjugate: Polysaccharide antigens linked to proteins to enhance immunogenicity (e.g., Hib, PCV7).

  • Recombinant antigen: Antigen produced in a non-pathogenic host (e.g., hepatitis B, HPV).

  • Nucleic acid vaccines: DNA or mRNA encoding antigen (e.g., COVID-19 vaccines).

Attenuation of virulence in vaccine production Vaccines for bacterial and viral diseases

Tables: Vaccines for Infectious Diseases

Bacterial Disease

Type of Vaccine

Anthrax

Toxoid

Cholera

Killed cells or extract

Diphtheria

Toxoid

Haemophilus influenzae type b

Conjugate

Meningitis

Purified polysaccharide

Pertussis

Killed bacteria or acellular proteins

Pneumonia

Purified polysaccharide or conjugate

Tetanus

Toxoid

Tuberculosis

Attenuated strain

Viral Disease

Type of Vaccine

Hepatitis A

Recombinant DNA vaccine

Hepatitis B

Recombinant DNA or inactivated virus

HPV

Recombinant DNA vaccine

Influenza

Inactivated or attenuated virus

Measles, mumps, rubella

Attenuated virus

Polio

Attenuated or inactivated virus

Rabies

Inactivated or attenuated virus

Rotavirus

Attenuated virus

Varicella

Attenuated virus

Additional info: This guide covers the immunological basis of hypersensitivity, autoimmunity, and vaccination, with emphasis on mechanisms, clinical examples, and public health relevance. It is suitable for exam preparation in a college-level microbiology course.

Pearson Logo

Study Prep